Label-Free, High-Throughput Drug Discovery and ADME
RapidFire performs label-free, high-throughput screening drug discovery to identify high-quality targets without the compromises of fluorescence or radioactivity. The same platform can drive workflows like protein binding, metabolic stability, and permeability. RapidFire combines high-throughput sample processing with triple quadrupole or time-of flight MS to streamline ADME assay analysis, with excellent correlation values compared to traditional LC/MS/MS analysis.
Search drug discovery and ADME application notes where RapidFire is used.

